Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018)

Siga Technologies (SIGA) posted Non-Current Deffered Revenue of $376.0 million for Q1 2018, little changed on a QoQ basis from $377.6 million in Q4 2017, and little changed year-over-year from $376.2 million in Q1 2017.

Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018) Analysis & Trends

Siga Technologies' Non-Current Deffered Revenue history runs 8 years deep, the most recent figure standing at $376.0 million for Q1 2018.

  • Quarterly Non-Current Deffered Revenue changed 0.05% year-over-year to $376.0 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $376.0 million (changed 0.05% YoY) and the FY2017 annual result came in at $377.6 million, up 2.76% from the prior year.
  • Non-Current Deffered Revenue was $376.0 million for Q1 2018 at Siga Technologies, roughly flat from $377.6 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $377.6 million in Q4 2017 and bottomed at $81799.0 in Q4 2014.
  • A 5-year average of $268.5 million and a median of $271.9 million in 2016 frame the typical range for Non-Current Deffered Revenue.
  • Annual changes were most pronounced in 2014 — Non-Current Deffered Revenue slumped 99.95% — and 2015, when it surged 311955.61%.
  • Siga Technologies' Non-Current Deffered Revenue stood at $81799.0 in 2014, then jumped by 311955.61% to $255.3 million in 2015, then jumped by 43.97% to $367.5 million in 2016, then climbed by 2.76% to $377.6 million in 2017, then slipped by 0.43% to $376.0 million in 2018.
  • Business Quant data shows SIGA's Non-Current Deffered Revenue at $376.0 million in Q1 2018, $377.6 million in Q4 2017, and $377.4 million in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Siga Technologies 225.56 Mn 70.59 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2018 376.03 Mn
Dec 31, 2017 377.64 Mn
Sep 30, 2017 377.45 Mn
Jun 30, 2017 376.48 Mn
Mar 31, 2017 376.20 Mn
Dec 31, 2016 367.48 Mn
Sep 30, 2016 367.12 Mn
Jun 30, 2016 288.29 Mn
Mar 31, 2016 255.47 Mn
Dec 31, 2015 255.26 Mn
Sep 30, 2015 255.09 Mn
Jun 30, 2015 233.74 Mn
Mar 31, 2015 13.53 Mn
Dec 31, 2014 81,799.00
Jun 30, 2014 188.08 Mn
Mar 31, 2014 187.78 Mn
Dec 31, 2013 162.22 Mn
Sep 30, 2013 162.06 Mn
Jun 30, 2013 119.07 Mn
Mar 31, 2013 83.51 Mn